Cargando…

Efficacy and Safety of Transcutaneous Electrical Acupoint Stimulation to Treat Muscle Spasticity following Brain Injury: A Double-Blinded, Multicenter, Randomized Controlled Trial

OBJECTIVE: This study was aimed at evaluating the clinical efficacy and safety of transcutaneous electrical acupoint stimulation (TEAS) to treat muscle spasticity after brain injury (Chinese Clinical Trial Registry: ChiCTR-TRC-11001310). METHODS: A total of 60 patients with muscle spasticity after b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Wenli, Wang, Chao, Li, Zhongzheng, Chen, Lei, Li, Jianbo, Cui, Weidong, Ding, Shasha, Xi, Qiang, Wang, Fan, Jia, Fei, Xiao, Shuhua, Guo, Yi, Zhao, Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314074/
https://www.ncbi.nlm.nih.gov/pubmed/25643051
http://dx.doi.org/10.1371/journal.pone.0116976
_version_ 1782355288357076992
author Zhao, Wenli
Wang, Chao
Li, Zhongzheng
Chen, Lei
Li, Jianbo
Cui, Weidong
Ding, Shasha
Xi, Qiang
Wang, Fan
Jia, Fei
Xiao, Shuhua
Guo, Yi
Zhao, Ye
author_facet Zhao, Wenli
Wang, Chao
Li, Zhongzheng
Chen, Lei
Li, Jianbo
Cui, Weidong
Ding, Shasha
Xi, Qiang
Wang, Fan
Jia, Fei
Xiao, Shuhua
Guo, Yi
Zhao, Ye
author_sort Zhao, Wenli
collection PubMed
description OBJECTIVE: This study was aimed at evaluating the clinical efficacy and safety of transcutaneous electrical acupoint stimulation (TEAS) to treat muscle spasticity after brain injury (Chinese Clinical Trial Registry: ChiCTR-TRC-11001310). METHODS: A total of 60 patients with muscle spasticity after brain injury were randomized to the following 3 groups: 100, 2, and 0 Hz (sham) TEAS. The acupoints Hegu (LI4)—Yuji (LU10) and Zusanli (ST36)—Chengshan (BL57) on the injured side were stimulated at 0, 2, or 100 Hz, 5 times per week for 4 weeks. The patients were followed up for 1 and 2 months after the treatments. The effects of the treatments on muscle spasticity at the wrist, thumb, the other 4 fingers, elbow, shoulder, knee, and ankle were evaluated by the Modified Ashworth Scale, and the effects on disability were assessed by the Disability Assessment Scale. The walking capability was evaluated by the Holden functional ambulation classification score. The overall performance was assessed by the Global Assessment Scale score and the improved Barthel Index. The safety of the treatments administered was also monitored. RESULTS: The wrist spasticity was significantly reduced from baseline at weeks 2, 3, and 4 of treatment and at the 1- and 2-month follow-up visits in the 100 Hz group (P < 0.01). Compared with 2 Hz or sham TEAS, 100 Hz TEAS decreased wrist spasticity at weeks 2, 3, and 4 of treatment and 1 month after treatment (P < 0.001). The other endpoints were not affected by the treatments. No treatment-emergent adverse events were reported during treatments and follow-up visits. CONCLUSIONS: TEAS appears to be a safe and effective therapy to relieve muscle spasticity after brain injury, although large-scale studies are required to further verify the findings. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR-TRC-11001310 http://www.chictr.org
format Online
Article
Text
id pubmed-4314074
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43140742015-02-13 Efficacy and Safety of Transcutaneous Electrical Acupoint Stimulation to Treat Muscle Spasticity following Brain Injury: A Double-Blinded, Multicenter, Randomized Controlled Trial Zhao, Wenli Wang, Chao Li, Zhongzheng Chen, Lei Li, Jianbo Cui, Weidong Ding, Shasha Xi, Qiang Wang, Fan Jia, Fei Xiao, Shuhua Guo, Yi Zhao, Ye PLoS One Research Article OBJECTIVE: This study was aimed at evaluating the clinical efficacy and safety of transcutaneous electrical acupoint stimulation (TEAS) to treat muscle spasticity after brain injury (Chinese Clinical Trial Registry: ChiCTR-TRC-11001310). METHODS: A total of 60 patients with muscle spasticity after brain injury were randomized to the following 3 groups: 100, 2, and 0 Hz (sham) TEAS. The acupoints Hegu (LI4)—Yuji (LU10) and Zusanli (ST36)—Chengshan (BL57) on the injured side were stimulated at 0, 2, or 100 Hz, 5 times per week for 4 weeks. The patients were followed up for 1 and 2 months after the treatments. The effects of the treatments on muscle spasticity at the wrist, thumb, the other 4 fingers, elbow, shoulder, knee, and ankle were evaluated by the Modified Ashworth Scale, and the effects on disability were assessed by the Disability Assessment Scale. The walking capability was evaluated by the Holden functional ambulation classification score. The overall performance was assessed by the Global Assessment Scale score and the improved Barthel Index. The safety of the treatments administered was also monitored. RESULTS: The wrist spasticity was significantly reduced from baseline at weeks 2, 3, and 4 of treatment and at the 1- and 2-month follow-up visits in the 100 Hz group (P < 0.01). Compared with 2 Hz or sham TEAS, 100 Hz TEAS decreased wrist spasticity at weeks 2, 3, and 4 of treatment and 1 month after treatment (P < 0.001). The other endpoints were not affected by the treatments. No treatment-emergent adverse events were reported during treatments and follow-up visits. CONCLUSIONS: TEAS appears to be a safe and effective therapy to relieve muscle spasticity after brain injury, although large-scale studies are required to further verify the findings. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR-TRC-11001310 http://www.chictr.org Public Library of Science 2015-02-02 /pmc/articles/PMC4314074/ /pubmed/25643051 http://dx.doi.org/10.1371/journal.pone.0116976 Text en © 2015 Zhao et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Zhao, Wenli
Wang, Chao
Li, Zhongzheng
Chen, Lei
Li, Jianbo
Cui, Weidong
Ding, Shasha
Xi, Qiang
Wang, Fan
Jia, Fei
Xiao, Shuhua
Guo, Yi
Zhao, Ye
Efficacy and Safety of Transcutaneous Electrical Acupoint Stimulation to Treat Muscle Spasticity following Brain Injury: A Double-Blinded, Multicenter, Randomized Controlled Trial
title Efficacy and Safety of Transcutaneous Electrical Acupoint Stimulation to Treat Muscle Spasticity following Brain Injury: A Double-Blinded, Multicenter, Randomized Controlled Trial
title_full Efficacy and Safety of Transcutaneous Electrical Acupoint Stimulation to Treat Muscle Spasticity following Brain Injury: A Double-Blinded, Multicenter, Randomized Controlled Trial
title_fullStr Efficacy and Safety of Transcutaneous Electrical Acupoint Stimulation to Treat Muscle Spasticity following Brain Injury: A Double-Blinded, Multicenter, Randomized Controlled Trial
title_full_unstemmed Efficacy and Safety of Transcutaneous Electrical Acupoint Stimulation to Treat Muscle Spasticity following Brain Injury: A Double-Blinded, Multicenter, Randomized Controlled Trial
title_short Efficacy and Safety of Transcutaneous Electrical Acupoint Stimulation to Treat Muscle Spasticity following Brain Injury: A Double-Blinded, Multicenter, Randomized Controlled Trial
title_sort efficacy and safety of transcutaneous electrical acupoint stimulation to treat muscle spasticity following brain injury: a double-blinded, multicenter, randomized controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314074/
https://www.ncbi.nlm.nih.gov/pubmed/25643051
http://dx.doi.org/10.1371/journal.pone.0116976
work_keys_str_mv AT zhaowenli efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial
AT wangchao efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial
AT lizhongzheng efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial
AT chenlei efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial
AT lijianbo efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial
AT cuiweidong efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial
AT dingshasha efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial
AT xiqiang efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial
AT wangfan efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial
AT jiafei efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial
AT xiaoshuhua efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial
AT guoyi efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial
AT zhaoye efficacyandsafetyoftranscutaneouselectricalacupointstimulationtotreatmusclespasticityfollowingbraininjuryadoubleblindedmulticenterrandomizedcontrolledtrial